US › Healthcare

Co-Diagnostics, Inc. Common Stock (CODX)

US · Healthcare · Medical Devices

$1.51+2.03%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$145,954
Revenue YoY
+190.3%
Net profit
$-9.1M
Profit YoY
-21.3%
EPS
$-4.09
EPS estimate
$-3.75
Net margin
-6,262.3%

EPS came in at -4.09 against a street estimate of -3.75 — a miss of 9.1%.

Key statistics

Market cap
$5.3M
Forward P/E
15.4
P/B
0.33
Book value
$4.45
EPS (TTM)
$-32.26
52-week high
$46.50
52-week low
$1.26
50-day MA
$3.75
200-day MA
$5.06
Beta
2.85

Analyst view

Analysts rate Co-Diagnostics, Inc. Common Stock a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $45.00.

Shareholding

Insiders
2.39%
Institutions
7.71%

Largest institutional holders

FundStake
Private Asset Group LLC1.12%
UBS Group AG0.20%
Morgan Stanley - Brokerage Accounts0.00%
Wells Fargo & Co0.00%
SBI Securities Co Ltd0.00%
JPMorgan Chase & Co0.00%
Heritage Wealth Advisors, LLC0.00%
Western Wealth Management, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Co-Diagnostics, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.